Rhumbline Advisers Zoetis Inc. Transaction History

Rhumbline Advisers

$105 Billion
Q2 2024

A detailed history of Rhumbline Advisers transactions in Zoetis Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 1,096,007 shares of ZTS stock, worth $215 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

1,096,007

Previous 1,110,255 1.28%

Holding current value

$215 Million

Previous $188 Million 1.14%

% of portfolio

0.18%

Previous 0.18%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	SELL	$145.54 - $178.83 $2.07 Million - $2.55 Million	-14,248 Reduced 1.28%	1,096,007 $190 Million
Q1 2024 May 09, 2024	BUY	$165.67 - $199.94 $11.9 Million - $14.4 Million	72,093 Added 6.94%	1,110,255 $188 Million
Q4 2023 Feb 08, 2024	SELL	$151.44 - $200.09 $1.74 Million - $2.3 Million	-11,509 Reduced 1.1%	1,038,162 $205 Million
Q3 2023 Nov 09, 2023	BUY	$167.14 - $192.77 $3.7 Million - $4.27 Million	22,164 Added 2.16%	1,049,671 $183 Million
Q2 2023 Aug 08, 2023	SELL	$160.94 - $186.23 $2.28 Million - $2.64 Million	-14,160 Reduced 1.36%	1,027,507 $177 Million
Q1 2023 May 11, 2023	BUY	$145.48 - $175.02 $2.72 Million - $3.27 Million	18,670 Added 1.83%	1,041,667 $173 Million
Q4 2022 Feb 14, 2023	BUY	$131.14 - $157.47 $5.83 Million - $7 Million	44,437 Added 4.54%	1,022,997 $150 Million
Q3 2022 Nov 10, 2022	BUY	$148.29 - $182.55 $618,517 - $761,416	4,171 Added 0.43%	978,560 $145 Million
Q2 2022 Aug 11, 2022	BUY	$155.97 - $200.09 $9.68 Million - $12.4 Million	62,052 Added 6.8%	974,389 $167 Million
Q1 2022 May 12, 2022	BUY	$181.39 - $234.03 $2.65 Million - $3.42 Million	14,628 Added 1.63%	912,337 $172 Million
Q4 2021 Feb 10, 2022	BUY	$193.69 - $247.03 $1.71 Million - $2.19 Million	8,849 Added 1.0%	897,709 $219 Million
Q3 2021 Nov 12, 2021	SELL	$189.29 - $209.69 $3.75 Million - $4.15 Million	-19,812 Reduced 2.18%	888,860 $173 Million
Q2 2021 Aug 05, 2021	SELL	$155.9 - $187.99 $8.52 Million - $10.3 Million	-54,621 Reduced 5.67%	908,672 $169 Million
Q1 2021 May 06, 2021	SELL	$144.0 - $169.39 $2 Million - $2.35 Million	-13,894 Reduced 1.42%	963,293 $152 Million
Q4 2020 Feb 10, 2021	SELL	$157.07 - $174.35 $1.21 Million - $1.34 Million	-7,676 Reduced 0.78%	977,187 $162 Million
Q3 2020 Nov 12, 2020	SELL	$137.1 - $165.37 $4.98 Million - $6.01 Million	-36,316 Reduced 3.56%	984,863 $163 Million
Q2 2020 Aug 13, 2020	BUY	$111.92 - $142.53 $1.02 Million - $1.29 Million	9,076 Added 0.9%	1,021,179 $140 Million
Q1 2020 May 06, 2020	BUY	$92.66 - $144.94 $1.06 Million - $1.66 Million	11,422 Added 1.14%	1,012,103 $119 Million
Q4 2019 Feb 05, 2020	SELL	$116.25 - $133.25 $295,507 - $338,721	-2,542 Reduced 0.25%	1,000,681 $132 Million
Q3 2019 Oct 23, 2019	BUY	$112.57 - $128.43 $3.6 Million - $4.11 Million	31,963 Added 3.29%	1,003,223 $125 Million
Q2 2019 Aug 14, 2019	SELL	$97.98 - $114.28 $1.64 Million - $1.91 Million	-16,756 Reduced 1.7%	971,260 $110 Million
Q1 2019 May 01, 2019	BUY	$81.56 - $100.67 $2.28 Million - $2.81 Million	27,912 Added 2.91%	988,016 $99.5 Million
Q4 2018 Jan 31, 2019	BUY	$79.28 - $95.27 $1.98 Million - $2.38 Million	24,931 Added 2.67%	960,104 $82.1 Million
Q3 2018 Nov 07, 2018	SELL	$83.5 - $93.23 $1.46 Million - $1.63 Million	-17,472 Reduced 1.83%	935,173 $85.6 Million
Q2 2018 Aug 06, 2018	SELL	$79.9 - $89.2 $5.76 Million - $6.43 Million	-72,123 Reduced 7.04%	952,645 $81.2 Million
Q1 2018 May 02, 2018	SELL	$71.51 - $84.69 $2.71 Million - $3.21 Million	-37,932 Reduced 3.57%	1,024,768 $85.6 Million
Q4 2017 Feb 09, 2018	BUY	$63.24 - $72.8 $976,172 - $1.12 Million	15,436 Added 1.47%	1,062,700 $76.6 Million
Q3 2017 Nov 06, 2017	BUY	$59.73 - $65.4 $62.6 Million - $68.5 Million	1,047,264	1,047,264 $66.8 Million

Others Institutions Holding ZTS

# of Institutions

1,897

Shares Held

423M

Call Options Held

1.15M

Put Options Held

1.2M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $92B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Zoetis Inc. Transaction History